Xoma | XOMA - Umsatzkosten





Umsatzkosten Veränderung Datum
AbbVie USD 4.55B 757M 2025-12
Agenus USD 642K 399K 2025-09
Agios Pharmaceuticals USD 1.88M 199K 2025-12
Ardelyx USD 10.85M 6.87M 2025-12
aTyr Pharma USD 3.34M 18.79M 2025-12
BioMarin Pharmaceutical USD 161.56M 16.62M 2025-12
Celldex Therapeutics USD 54.2M 8.94M 2025-06
Curis USD 314K 9.96M 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Emergent BioSolutions USD 381.2M 226.1M 2023-06
Incyte USD 121.18M 22.18M 2025-12
MacroGenics USD 10.12M 34.18M 2025-12
Novartis USD 3.54B 3M 2025-12
Novartis USD 3.54B 7M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Prothena USD 28.94M 11.58M 2025-09
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Xoma 116K 112.7K 2024-06